Left Atrial Appendage (LAA) Occluders

Videos | 3-D Printing | November 17, 2017

Dee Dee Wang, M.D., Director, Structural Heart Imaging at Henry Ford Hospital, Detroit, explains how her center uses...

Videos | Left Atrial Appendage (LAA) Occluders | November 14, 2017

Vivek Reddy, M.D., director of cardiac arrhythmia services and professor of medicine, cardiology, Mount Sinai...

LAA closure during open heart surgery in the LAACS Study showed better outcomes for all patients.

LAA closure during open heart surgery in the LAACS Study showed better outcomes for all patients.

Feature | Left Atrial Appendage (LAA) Occluders | September 07, 2017

September 7, 2017 — Closure of the left atrial appendage (LAA) during heart surgery protects the brain, according to...

AtriCure's AtriClip System Surpasses 100,000 Units Sold Worldwide
News | Left Atrial Appendage (LAA) Occluders | April 25, 2017

April 25, 2017 — AtriCure Inc. announced it has sold more than 100,000 AtriClip Left Atrial Appendage Exclusion...

atricure atriclip, LAA occlusion, acc17

The AtriCure Atriclip surgical LAA occlusion device. It loops over the LAA on the outside of the heart and clips it off from the rest of the heart to prevent the formation of clots.

Feature | Left Atrial Appendage (LAA) Occluders | March 29, 2017

March 29, 2017 — For patients with...

Aegis Medical Innovations, Sierra Ligation System, U.S. clinical trial, FDA approval, LAA occluder
Technology | Left Atrial Appendage (LAA) Occluders | March 22, 2017

March 22, 2017 — Aegis Medical Innovations Inc. announced that it has received Investigational Device Exemption...

Dee Dee Wang, Henry Ford Hospital, 3D printing for cardiology, 3-D

Dr. Dee Dee Wang with part of Henry Ford Hospital's collection of 3-D printed hearts used for education and to preplan structural heart procedures.

Feature | 3-D Printing | March 03, 2017

March 3, 2017 — A Henry Ford Hospital study found a 100 percent success rate in left atrial appendage (LAA)...

SentreHeart, Lariat Suture Delivery Device, aMAZE Trial, Stage I, enrollment complete
News | Left Atrial Appendage (LAA) Occluders | January 06, 2017

January 6, 2017 — SentreHeart Inc. announced that it has completed the Stage I enrollment milestone in the aMAZE...

watchman LAA occluder, LAAO registry
Feature | Left Atrial Appendage (LAA) Occluders | November 07, 2016

November 7, 2016 – Results from the U.S. real-world, post-FDA approval experience of the Watchman device found high...

UAB, University of Alabama at Birmingham study, stroke prevention, non-valvular atrial fibrillation, NVAF
News | Atrial Fibrillation | October 25, 2016

October 25, 2016 — A recent study from University of Alabama at Birmingham (UAB) researchers published in PLOS ONE ...

SentreHeart, Lariat Suture Delivery Device, financing round, aMAZE Trial
News | Left Atrial Appendage (LAA) Occluders | October 20, 2016

October 20, 2016 — SentreHeart Inc. announced in late September the closing of a $35 million Series D round of...

SentreHeart, Eclipse Surgical Device, left atrial appendage, LAA closure, first clinical use, Poland
News | Left Atrial Appendage (LAA) Occluders | October 13, 2016

October 13, 2016 — SentreHeart Inc. announced this week it has treated the first patients using the Eclipse Surgical...

CardioKinetix, Parachute device, Heart Failure device therapy

The CardioKinetix Parachute device implant shown deployed in the left ventricle of a heart failure patient. The device helps remodel the ventricle to improve the heart's ability to pump blood more efficiently. 

Feature | Heart Failure | September 29, 2016 | Abha Mishra

New cardiovascular device therapies for atrial fibrillation (AF) and heart failure (HF) are rapidly evolving with...

St. Jude Medical, Amplatzer Amulet LAA occluder, left atrial appendage, IDE trial
News | Left Atrial Appendage (LAA) Occluders | September 02, 2016

September 2, 2016 — St. Jude Medical Inc. announced the start of the St. Jude Medical Amplatzer Amulet IDE trial of...

Absorb, bioresorbable stent, FDA approval, FDA approves, FDA clears, most popular content, most popular stories, DAIC

The FDA clearance of the first bioresorbable stent, the Abbott Absorb, the first week of July has been the most popular story so far for all of 2016. It is the first fully dissolving stent approved for the U.S. market and many experts say this technology could be a paradigm shift in coronary and peripheral therapies in the coming years as the technology improves. 

Feature | August 05, 2016 | Dave Fornell

 

August 5, 2016 — Here are the top 20 most popular current content on the Diagnostic and Interventional...

Overlay Init